Roivant Sciences Ltd (NASDAQ: ROIV) established initial surge of 2.01% at $21.32, as the Stock market unbolted on Wednesday, before settling in for the price of $20.9 at the close. Taking a more long-term approach, ROIV posted a 52-week range of $8.73-$21.35.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -99.51%. Meanwhile, its Annual Earning per share during the time was -99.51%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -402.14%. This publicly-traded company’s shares outstanding now amounts to $689.70 million, simultaneously with a float of $410.79 million. The organization now has a market capitalization sitting at $14.83 billion. At the time of writing, stock’s 50-day Moving Average stood at $16.69, while the 200-day Moving Average is $12.42.
Roivant Sciences Ltd (ROIV) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Roivant Sciences Ltd industry. Roivant Sciences Ltd’s current insider ownership accounts for 39.18%, in contrast to 64.13% institutional ownership. According to the most recent insider trade that took place on Nov 07 ’25, this organization’s President & Immunovant CEO sold 200,000 shares at the rate of 20.22, making the entire transaction reach 4,044,000 in total value, affecting insider ownership by 1,504,959.
Roivant Sciences Ltd (ROIV) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
Roivant Sciences Ltd’s EPS decrease for this current 12-month fiscal period is -402.14% and is forecasted to reach -1.39 in the upcoming year.
Roivant Sciences Ltd (NASDAQ: ROIV) Trading Performance Indicators
Let’s observe the current performance indicators for Roivant Sciences Ltd (ROIV). It’s Quick Ratio in the last reported quarter now stands at 33.70. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 729.36.
In the same vein, ROIV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.55, a figure that is expected to reach -0.32 in the next quarter, and analysts are predicting that it will be -1.39 at the market close of one year from today.
Technical Analysis of Roivant Sciences Ltd (ROIV)
Now, what If we examine the latest scores posted by [Roivant Sciences Ltd, ROIV]. During the last 5-days, its volume was better the volume of 6.52 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 91.81% While, its Average True Range was 81.80.
Raw Stochastic average of Roivant Sciences Ltd (ROIV) in the period of the previous 100 days is set at 99.72%, which indicates a major rise in contrast to 99.13% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.73 that was higher than 0.42 volatility it exhibited in the past 100-days period.
